0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ursodeoxycholic Acid Drug Market Research Report 2026
Published Date: 2026-04-29
|
Report Code: QYRE-Auto-34A18467
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Ursodeoxycholic Acid Drug Market Research Report 2024
BUY CHAPTERS

Global Ursodeoxycholic Acid Drug Market Research Report 2026

Code: QYRE-Auto-34A18467
Report
2026-04-29
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Ursodeoxycholic Acid Drug Market Size

The global Ursodeoxycholic Acid Drug market was valued at US$ 1320 million in 2025 and is anticipated to reach US$ 1674 million by 2032, at a CAGR of 3.5% from 2026 to 2032.

Ursodeoxycholic Acid Drug Market

Ursodeoxycholic Acid Drug Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ursodeoxycholic Acid Drug competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
In this report, we study the drugs of UDCA.
The Ursodeoxycholic Acid (UDCA) drug market is primarily driven by the increasing prevalence of liver and gallbladder diseases, such as primary biliary cholangitis (PBC), cholestatic liver disorders, and gallstones. The rising awareness about early diagnosis and treatment of liver-related conditions has spurred demand for effective therapeutics like UDCA. Additionally, the aging population and increasing incidences of lifestyle-related disorders, such as obesity and metabolic syndrome, which contribute to liver diseases, further fuel market growth. Advances in pharmaceutical formulations and expanded indications for UDCA use in pediatric and off-label treatments also bolster its adoption.
Despite its benefits, the UDCA drug market faces significant challenges, including the availability of alternative treatments like obeticholic acid and surgical options for gallstone management. Moreover, the high cost of branded UDCA medications limits accessibility in low- and middle-income countries. Patent expirations and the subsequent influx of generic drugs have intensified market competition, putting pressure on pricing and margins. Regulatory hurdles and the need for extensive clinical trials to validate new indications for UDCA also add to the complexity of market expansion.
North America is the largest sales place, with a sales market share nearly 30% in 2023. Following North America, Europe is the second largest sales place with market share of 22%. Ursodeoxycholic Acid Drug Product market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India. Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, etc. are the global leading manufactures in the world. In the future, more generic manufacturers will enter into this industry. In North America, Epic Pharma is leading manufacturers, Teva, Lannett and Mylan are major suppliers of Ursodeoxycholic Acid Drug Product in USA market. In China, Dr. Falk Pharma is leading manufacturers
This report delivers a comprehensive overview of the global Ursodeoxycholic Acid Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ursodeoxycholic Acid Drug. The Ursodeoxycholic Acid Drug market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Ursodeoxycholic Acid Drug market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Ursodeoxycholic Acid Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Ursodeoxycholic Acid Drug Market Report

Report Metric Details
Report Name Ursodeoxycholic Acid Drug Market
Accounted market size in 2025 US$ 1320 million
Forecasted market size in 2032 US$ 1674 million
CAGR 3.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Capsule
  • Tablet
by Application
  • Gallstone
  • Hepatopathy
  • Biliary Disease
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Epic Pharma, Mitsubishi Tanabe Pharma, Lannett, Viatris, Bruschettini, Nichiiko, Shanghai Pharma, Grindeks, PRO.MED.CS Praha, Abbott Laboratories, Sun Pharmaceutical, Azpharm Group, SINOTHERAPEUTICS, Ccl Pharmaceuticals, Win-Medicare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Ursodeoxycholic Acid Drug manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Ursodeoxycholic Acid Drug sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Ursodeoxycholic Acid Drug Market growing?

Ans: The Ursodeoxycholic Acid Drug Market witnessing a CAGR of 3.5% during the forecast period 2026-2032.

What is the Ursodeoxycholic Acid Drug Market size in 2032?

Ans: The Ursodeoxycholic Acid Drug Market size in 2032 will be US$ 1674 million.

What is the Ursodeoxycholic Acid Drug Market share by region?

Ans: North America is the largest sales place, with a sales market share nearly 30% in 2023.

Who are the main players in the Ursodeoxycholic Acid Drug Market report?

Ans: The main players in the Ursodeoxycholic Acid Drug Market are Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Epic Pharma, Mitsubishi Tanabe Pharma, Lannett, Viatris, Bruschettini, Nichiiko, Shanghai Pharma, Grindeks, PRO.MED.CS Praha, Abbott Laboratories, Sun Pharmaceutical, Azpharm Group, SINOTHERAPEUTICS, Ccl Pharmaceuticals, Win-Medicare

What are the Application segmentation covered in the Ursodeoxycholic Acid Drug Market report?

Ans: The Applications covered in the Ursodeoxycholic Acid Drug Market report are Gallstone, Hepatopathy, Biliary Disease, Other

What are the Type segmentation covered in the Ursodeoxycholic Acid Drug Market report?

Ans: The Types covered in the Ursodeoxycholic Acid Drug Market report are Capsule, Tablet

1 Ursodeoxycholic Acid Drug Market Overview
1.1 Product Definition
1.2 Ursodeoxycholic Acid Drug by Type
1.2.1 Global Ursodeoxycholic Acid Drug Market Value by Type: 2025 vs 2032
1.2.2 Capsule
1.2.3 Tablet
1.3 Ursodeoxycholic Acid Drug by Application
1.3.1 Global Ursodeoxycholic Acid Drug Market Value by Application: 2025 vs 2032
1.3.2 Gallstone
1.3.3 Hepatopathy
1.3.4 Biliary Disease
1.3.5 Other
1.4 Global Ursodeoxycholic Acid Drug Market Size Estimates and Forecasts
1.4.1 Global Ursodeoxycholic Acid Drug Revenue 2021–2032
1.4.2 Global Ursodeoxycholic Acid Drug Sales 2021–2032
1.4.3 Global Ursodeoxycholic Acid Drug Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Ursodeoxycholic Acid Drug Market Competition by Manufacturers
2.1 Global Ursodeoxycholic Acid Drug Sales Market Share by Manufacturers (2021–2026)
2.2 Global Ursodeoxycholic Acid Drug Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Ursodeoxycholic Acid Drug Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Ursodeoxycholic Acid Drug, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Ursodeoxycholic Acid Drug, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Ursodeoxycholic Acid Drug, Product Types and Applications
2.7 Global Key Manufacturers of Ursodeoxycholic Acid Drug, Date of Entry into the Industry
2.8 Global Ursodeoxycholic Acid Drug Market Competitive Situation and Trends
2.8.1 Global Ursodeoxycholic Acid Drug Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Ursodeoxycholic Acid Drug Players Market Share by Revenue
2.8.3 Global Ursodeoxycholic Acid Drug Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ursodeoxycholic Acid Drug Market Scenario by Region
3.1 Global Ursodeoxycholic Acid Drug Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Ursodeoxycholic Acid Drug Sales by Region: 2021–2032
3.2.1 Global Ursodeoxycholic Acid Drug Sales by Region: 2021–2026
3.2.2 Global Ursodeoxycholic Acid Drug Sales by Region: 2027–2032
3.3 Global Ursodeoxycholic Acid Drug Revenue by Region: 2021–2032
3.3.1 Global Ursodeoxycholic Acid Drug Revenue by Region: 2021–2026
3.3.2 Global Ursodeoxycholic Acid Drug Revenue by Region: 2027–2032
3.4 North America Ursodeoxycholic Acid Drug Market Facts & Figures by Country
3.4.1 North America Ursodeoxycholic Acid Drug Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Ursodeoxycholic Acid Drug Sales by Country (2021–2032)
3.4.3 North America Ursodeoxycholic Acid Drug Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ursodeoxycholic Acid Drug Market Facts & Figures by Country
3.5.1 Europe Ursodeoxycholic Acid Drug Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Ursodeoxycholic Acid Drug Sales by Country (2021–2032)
3.5.3 Europe Ursodeoxycholic Acid Drug Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ursodeoxycholic Acid Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Ursodeoxycholic Acid Drug Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Ursodeoxycholic Acid Drug Sales by Region (2021–2032)
3.6.3 Asia Pacific Ursodeoxycholic Acid Drug Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ursodeoxycholic Acid Drug Market Facts & Figures by Country
3.7.1 Latin America Ursodeoxycholic Acid Drug Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Ursodeoxycholic Acid Drug Sales by Country (2021–2032)
3.7.3 Latin America Ursodeoxycholic Acid Drug Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Ursodeoxycholic Acid Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Ursodeoxycholic Acid Drug Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Ursodeoxycholic Acid Drug Sales by Country (2021–2032)
3.8.3 Middle East and Africa Ursodeoxycholic Acid Drug Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ursodeoxycholic Acid Drug Sales by Type (2021–2032)
4.1.1 Global Ursodeoxycholic Acid Drug Sales by Type (2021–2026)
4.1.2 Global Ursodeoxycholic Acid Drug Sales by Type (2027–2032)
4.1.3 Global Ursodeoxycholic Acid Drug Sales Market Share by Type (2021–2032)
4.2 Global Ursodeoxycholic Acid Drug Revenue by Type (2021–2032)
4.2.1 Global Ursodeoxycholic Acid Drug Revenue by Type (2021–2026)
4.2.2 Global Ursodeoxycholic Acid Drug Revenue by Type (2027–2032)
4.2.3 Global Ursodeoxycholic Acid Drug Revenue Market Share by Type (2021–2032)
4.3 Global Ursodeoxycholic Acid Drug Price by Type (2021–2032)
5 Segment by Application
5.1 Global Ursodeoxycholic Acid Drug Sales by Application (2021–2032)
5.1.1 Global Ursodeoxycholic Acid Drug Sales by Application (2021–2026)
5.1.2 Global Ursodeoxycholic Acid Drug Sales by Application (2027–2032)
5.1.3 Global Ursodeoxycholic Acid Drug Sales Market Share by Application (2021–2032)
5.2 Global Ursodeoxycholic Acid Drug Revenue by Application (2021–2032)
5.2.1 Global Ursodeoxycholic Acid Drug Revenue by Application (2021–2026)
5.2.2 Global Ursodeoxycholic Acid Drug Revenue by Application (2027–2032)
5.2.3 Global Ursodeoxycholic Acid Drug Revenue Market Share by Application (2021–2032)
5.3 Global Ursodeoxycholic Acid Drug Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Dr. Falk Pharma
6.1.1 Dr. Falk Pharma Company Information
6.1.2 Dr. Falk Pharma Description and Business Overview
6.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Portfolio
6.1.5 Dr. Falk Pharma Recent Developments/Updates
6.2 Daewoong Pharmaceutical
6.2.1 Daewoong Pharmaceutical Company Information
6.2.2 Daewoong Pharmaceutical Description and Business Overview
6.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Portfolio
6.2.5 Daewoong Pharmaceutical Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Teva Ursodeoxycholic Acid Drug Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Epic Pharma
6.4.1 Epic Pharma Company Information
6.4.2 Epic Pharma Description and Business Overview
6.4.3 Epic Pharma Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Epic Pharma Ursodeoxycholic Acid Drug Product Portfolio
6.4.5 Epic Pharma Recent Developments/Updates
6.5 Mitsubishi Tanabe Pharma
6.5.1 Mitsubishi Tanabe Pharma Company Information
6.5.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Portfolio
6.5.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.6 Lannett
6.6.1 Lannett Company Information
6.6.2 Lannett Description and Business Overview
6.6.3 Lannett Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Lannett Ursodeoxycholic Acid Drug Product Portfolio
6.6.5 Lannett Recent Developments/Updates
6.7 Viatris
6.7.1 Viatris Company Information
6.7.2 Viatris Description and Business Overview
6.7.3 Viatris Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Viatris Ursodeoxycholic Acid Drug Product Portfolio
6.7.5 Viatris Recent Developments/Updates
6.8 Bruschettini
6.8.1 Bruschettini Company Information
6.8.2 Bruschettini Description and Business Overview
6.8.3 Bruschettini Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Bruschettini Ursodeoxycholic Acid Drug Product Portfolio
6.8.5 Bruschettini Recent Developments/Updates
6.9 Nichiiko
6.9.1 Nichiiko Company Information
6.9.2 Nichiiko Description and Business Overview
6.9.3 Nichiiko Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Nichiiko Ursodeoxycholic Acid Drug Product Portfolio
6.9.5 Nichiiko Recent Developments/Updates
6.10 Shanghai Pharma
6.10.1 Shanghai Pharma Company Information
6.10.2 Shanghai Pharma Description and Business Overview
6.10.3 Shanghai Pharma Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Shanghai Pharma Ursodeoxycholic Acid Drug Product Portfolio
6.10.5 Shanghai Pharma Recent Developments/Updates
6.11 Grindeks
6.11.1 Grindeks Company Information
6.11.2 Grindeks Description and Business Overview
6.11.3 Grindeks Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Grindeks Ursodeoxycholic Acid Drug Product Portfolio
6.11.5 Grindeks Recent Developments/Updates
6.12 PRO.MED.CS Praha
6.12.1 PRO.MED.CS Praha Company Information
6.12.2 PRO.MED.CS Praha Description and Business Overview
6.12.3 PRO.MED.CS Praha Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 PRO.MED.CS Praha Ursodeoxycholic Acid Drug Product Portfolio
6.12.5 PRO.MED.CS Praha Recent Developments/Updates
6.13 Abbott Laboratories
6.13.1 Abbott Laboratories Company Information
6.13.2 Abbott Laboratories Description and Business Overview
6.13.3 Abbott Laboratories Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Abbott Laboratories Ursodeoxycholic Acid Drug Product Portfolio
6.13.5 Abbott Laboratories Recent Developments/Updates
6.14 Sun Pharmaceutical
6.14.1 Sun Pharmaceutical Company Information
6.14.2 Sun Pharmaceutical Description and Business Overview
6.14.3 Sun Pharmaceutical Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Sun Pharmaceutical Ursodeoxycholic Acid Drug Product Portfolio
6.14.5 Sun Pharmaceutical Recent Developments/Updates
6.15 Azpharm Group
6.15.1 Azpharm Group Company Information
6.15.2 Azpharm Group Description and Business Overview
6.15.3 Azpharm Group Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Azpharm Group Ursodeoxycholic Acid Drug Product Portfolio
6.15.5 Azpharm Group Recent Developments/Updates
6.16 SINOTHERAPEUTICS
6.16.1 SINOTHERAPEUTICS Company Information
6.16.2 SINOTHERAPEUTICS Description and Business Overview
6.16.3 SINOTHERAPEUTICS Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 SINOTHERAPEUTICS Ursodeoxycholic Acid Drug Product Portfolio
6.16.5 SINOTHERAPEUTICS Recent Developments/Updates
6.17 Ccl Pharmaceuticals
6.17.1 Ccl Pharmaceuticals Company Information
6.17.2 Ccl Pharmaceuticals Description and Business Overview
6.17.3 Ccl Pharmaceuticals Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Ccl Pharmaceuticals Ursodeoxycholic Acid Drug Product Portfolio
6.17.5 Ccl Pharmaceuticals Recent Developments/Updates
6.18 Win-Medicare
6.18.1 Win-Medicare Company Information
6.18.2 Win-Medicare Description and Business Overview
6.18.3 Win-Medicare Ursodeoxycholic Acid Drug Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Win-Medicare Ursodeoxycholic Acid Drug Product Portfolio
6.18.5 Win-Medicare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ursodeoxycholic Acid Drug Industry Chain Analysis
7.2 Ursodeoxycholic Acid Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ursodeoxycholic Acid Drug Production Mode & Process Analysis
7.4 Ursodeoxycholic Acid Drug Sales and Marketing
7.4.1 Ursodeoxycholic Acid Drug Sales Channels
7.4.2 Ursodeoxycholic Acid Drug Distributors
7.5 Ursodeoxycholic Acid Drug Customer Analysis
8 Ursodeoxycholic Acid Drug Market Dynamics
8.1 Ursodeoxycholic Acid Drug Industry Trends
8.2 Ursodeoxycholic Acid Drug Market Drivers
8.3 Ursodeoxycholic Acid Drug Market Challenges
8.4 Ursodeoxycholic Acid Drug Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Ursodeoxycholic Acid Drug Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Ursodeoxycholic Acid Drug Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Ursodeoxycholic Acid Drug Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Ursodeoxycholic Acid Drug Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Ursodeoxycholic Acid Drug Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Ursodeoxycholic Acid Drug Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Ursodeoxycholic Acid Drug Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Ursodeoxycholic Acid Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Ursodeoxycholic Acid Drug, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Ursodeoxycholic Acid Drug, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Ursodeoxycholic Acid Drug, Product Types and Applications
 Table 12. Global Key Manufacturers of Ursodeoxycholic Acid Drug, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ursodeoxycholic Acid Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Ursodeoxycholic Acid Drug Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ursodeoxycholic Acid Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Ursodeoxycholic Acid Drug Sales by Region (K Units), 2021–2026
 Table 18. Global Ursodeoxycholic Acid Drug Sales Market Share by Region (2021–2026)
 Table 19. Global Ursodeoxycholic Acid Drug Sales by Region (K Units), 2027–2032
 Table 20. Global Ursodeoxycholic Acid Drug Sales Market Share by Region (2027–2032)
 Table 21. Global Ursodeoxycholic Acid Drug Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Ursodeoxycholic Acid Drug Revenue Market Share by Region (2021–2026)
 Table 23. Global Ursodeoxycholic Acid Drug Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Ursodeoxycholic Acid Drug Revenue Market Share by Region (2027–2032)
 Table 25. North America Ursodeoxycholic Acid Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Ursodeoxycholic Acid Drug Sales by Country (K Units), 2021–2026
 Table 27. North America Ursodeoxycholic Acid Drug Sales by Country (K Units), 2027–2032
 Table 28. North America Ursodeoxycholic Acid Drug Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Ursodeoxycholic Acid Drug Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Ursodeoxycholic Acid Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Ursodeoxycholic Acid Drug Sales by Country (K Units), 2021–2026
 Table 32. Europe Ursodeoxycholic Acid Drug Sales by Country (K Units), 2027–2032
 Table 33. Europe Ursodeoxycholic Acid Drug Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Ursodeoxycholic Acid Drug Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Ursodeoxycholic Acid Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Ursodeoxycholic Acid Drug Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Ursodeoxycholic Acid Drug Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Ursodeoxycholic Acid Drug Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Ursodeoxycholic Acid Drug Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Ursodeoxycholic Acid Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Ursodeoxycholic Acid Drug Sales by Country (K Units), 2021–2026
 Table 42. Latin America Ursodeoxycholic Acid Drug Sales by Country (K Units), 2027–2032
 Table 43. Latin America Ursodeoxycholic Acid Drug Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Ursodeoxycholic Acid Drug Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Ursodeoxycholic Acid Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Ursodeoxycholic Acid Drug Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Ursodeoxycholic Acid Drug Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Ursodeoxycholic Acid Drug Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Ursodeoxycholic Acid Drug Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Ursodeoxycholic Acid Drug Sales (K Units) by Type (2021–2026)
 Table 51. Global Ursodeoxycholic Acid Drug Sales (K Units) by Type (2027–2032)
 Table 52. Global Ursodeoxycholic Acid Drug Sales Market Share by Type (2021–2026)
 Table 53. Global Ursodeoxycholic Acid Drug Sales Market Share by Type (2027–2032)
 Table 54. Global Ursodeoxycholic Acid Drug Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Ursodeoxycholic Acid Drug Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Ursodeoxycholic Acid Drug Revenue Market Share by Type (2021–2026)
 Table 57. Global Ursodeoxycholic Acid Drug Revenue Market Share by Type (2027–2032)
 Table 58. Global Ursodeoxycholic Acid Drug Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Ursodeoxycholic Acid Drug Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Ursodeoxycholic Acid Drug Sales (K Units) by Application (2021–2026)
 Table 61. Global Ursodeoxycholic Acid Drug Sales (K Units) by Application (2027–2032)
 Table 62. Global Ursodeoxycholic Acid Drug Sales Market Share by Application (2021–2026)
 Table 63. Global Ursodeoxycholic Acid Drug Sales Market Share by Application (2027–2032)
 Table 64. Global Ursodeoxycholic Acid Drug Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Ursodeoxycholic Acid Drug Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Ursodeoxycholic Acid Drug Revenue Market Share by Application (2021–2026)
 Table 67. Global Ursodeoxycholic Acid Drug Revenue Market Share by Application (2027–2032)
 Table 68. Global Ursodeoxycholic Acid Drug Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Ursodeoxycholic Acid Drug Price (US$/Unit) by Application (2027–2032)
 Table 70. Dr. Falk Pharma Company Information
 Table 71. Dr. Falk Pharma Description and Business Overview
 Table 72. Dr. Falk Pharma Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Dr. Falk Pharma Ursodeoxycholic Acid Drug Product
 Table 74. Dr. Falk Pharma Recent Developments/Updates
 Table 75. Daewoong Pharmaceutical Company Information
 Table 76. Daewoong Pharmaceutical Description and Business Overview
 Table 77. Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product
 Table 79. Daewoong Pharmaceutical Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Teva Ursodeoxycholic Acid Drug Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Epic Pharma Company Information
 Table 86. Epic Pharma Description and Business Overview
 Table 87. Epic Pharma Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Epic Pharma Ursodeoxycholic Acid Drug Product
 Table 89. Epic Pharma Recent Developments/Updates
 Table 90. Mitsubishi Tanabe Pharma Company Information
 Table 91. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 92. Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product
 Table 94. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 95. Lannett Company Information
 Table 96. Lannett Description and Business Overview
 Table 97. Lannett Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Lannett Ursodeoxycholic Acid Drug Product
 Table 99. Lannett Recent Developments/Updates
 Table 100. Viatris Company Information
 Table 101. Viatris Description and Business Overview
 Table 102. Viatris Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Viatris Ursodeoxycholic Acid Drug Product
 Table 104. Viatris Recent Developments/Updates
 Table 105. Bruschettini Company Information
 Table 106. Bruschettini Description and Business Overview
 Table 107. Bruschettini Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Bruschettini Ursodeoxycholic Acid Drug Product
 Table 109. Bruschettini Recent Developments/Updates
 Table 110. Nichiiko Company Information
 Table 111. Nichiiko Description and Business Overview
 Table 112. Nichiiko Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Nichiiko Ursodeoxycholic Acid Drug Product
 Table 114. Nichiiko Recent Developments/Updates
 Table 115. Shanghai Pharma Company Information
 Table 116. Shanghai Pharma Description and Business Overview
 Table 117. Shanghai Pharma Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Shanghai Pharma Ursodeoxycholic Acid Drug Product
 Table 119. Shanghai Pharma Recent Developments/Updates
 Table 120. Grindeks Company Information
 Table 121. Grindeks Description and Business Overview
 Table 122. Grindeks Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Grindeks Ursodeoxycholic Acid Drug Product
 Table 124. Grindeks Recent Developments/Updates
 Table 125. PRO.MED.CS Praha Company Information
 Table 126. PRO.MED.CS Praha Description and Business Overview
 Table 127. PRO.MED.CS Praha Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. PRO.MED.CS Praha Ursodeoxycholic Acid Drug Product
 Table 129. PRO.MED.CS Praha Recent Developments/Updates
 Table 130. Abbott Laboratories Company Information
 Table 131. Abbott Laboratories Description and Business Overview
 Table 132. Abbott Laboratories Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Abbott Laboratories Ursodeoxycholic Acid Drug Product
 Table 134. Abbott Laboratories Recent Developments/Updates
 Table 135. Sun Pharmaceutical Company Information
 Table 136. Sun Pharmaceutical Description and Business Overview
 Table 137. Sun Pharmaceutical Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Sun Pharmaceutical Ursodeoxycholic Acid Drug Product
 Table 139. Sun Pharmaceutical Recent Developments/Updates
 Table 140. Azpharm Group Company Information
 Table 141. Azpharm Group Description and Business Overview
 Table 142. Azpharm Group Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Azpharm Group Ursodeoxycholic Acid Drug Product
 Table 144. Azpharm Group Recent Developments/Updates
 Table 145. SINOTHERAPEUTICS Company Information
 Table 146. SINOTHERAPEUTICS Description and Business Overview
 Table 147. SINOTHERAPEUTICS Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. SINOTHERAPEUTICS Ursodeoxycholic Acid Drug Product
 Table 149. SINOTHERAPEUTICS Recent Developments/Updates
 Table 150. Ccl Pharmaceuticals Company Information
 Table 151. Ccl Pharmaceuticals Description and Business Overview
 Table 152. Ccl Pharmaceuticals Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Ccl Pharmaceuticals Ursodeoxycholic Acid Drug Product
 Table 154. Ccl Pharmaceuticals Recent Developments/Updates
 Table 155. Win-Medicare Company Information
 Table 156. Win-Medicare Description and Business Overview
 Table 157. Win-Medicare Ursodeoxycholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Win-Medicare Ursodeoxycholic Acid Drug Product
 Table 159. Win-Medicare Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Ursodeoxycholic Acid Drug Distributors List
 Table 163. Ursodeoxycholic Acid Drug Customers List
 Table 164. Ursodeoxycholic Acid Drug Market Trends
 Table 165. Ursodeoxycholic Acid Drug Market Drivers
 Table 166. Ursodeoxycholic Acid Drug Market Challenges
 Table 167. Ursodeoxycholic Acid Drug Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ursodeoxycholic Acid Drug
 Figure 2. Global Ursodeoxycholic Acid Drug Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Ursodeoxycholic Acid Drug Market Share by Type: 2025 & 2032
 Figure 4. Capsule Product Picture
 Figure 5. Tablet Product Picture
 Figure 6. Global Ursodeoxycholic Acid Drug Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Ursodeoxycholic Acid Drug Market Share by Application: 2025 & 2032
 Figure 8. Gallstone
 Figure 9. Hepatopathy
 Figure 10. Biliary Disease
 Figure 11. Other
 Figure 12. Global Ursodeoxycholic Acid Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Ursodeoxycholic Acid Drug Market Size (US$ Million), 2021–2032
 Figure 14. Global Ursodeoxycholic Acid Drug Sales (K Units), 2021–2032
 Figure 15. Global Ursodeoxycholic Acid Drug Average Price (US$/Unit), 2021–2032
 Figure 16. Ursodeoxycholic Acid Drug Report Years Considered
 Figure 17. Ursodeoxycholic Acid Drug Sales Share by Manufacturers in 2025
 Figure 18. Global Ursodeoxycholic Acid Drug Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Ursodeoxycholic Acid Drug Players: Market Share by Revenue in Ursodeoxycholic Acid Drug in 2025
 Figure 20. Ursodeoxycholic Acid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Ursodeoxycholic Acid Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Ursodeoxycholic Acid Drug Sales Market Share by Country (2021–2032)
 Figure 23. North America Ursodeoxycholic Acid Drug Revenue Market Share by Country (2021–2032)
 Figure 24. United States Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Ursodeoxycholic Acid Drug Sales Market Share by Country (2021–2032)
 Figure 27. Europe Ursodeoxycholic Acid Drug Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Ursodeoxycholic Acid Drug Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Ursodeoxycholic Acid Drug Revenue Market Share by Region (2021–2032)
 Figure 35. China Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Ursodeoxycholic Acid Drug Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Ursodeoxycholic Acid Drug Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Ursodeoxycholic Acid Drug Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Ursodeoxycholic Acid Drug Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Ursodeoxycholic Acid Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Ursodeoxycholic Acid Drug by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Ursodeoxycholic Acid Drug by Type (2021–2032)
 Figure 55. Global Ursodeoxycholic Acid Drug Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Ursodeoxycholic Acid Drug by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Ursodeoxycholic Acid Drug by Application (2021–2032)
 Figure 58. Global Ursodeoxycholic Acid Drug Price (US$/Unit) by Application (2021–2032)
 Figure 59. Ursodeoxycholic Acid Drug Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools